KRRO Earnings Korro Bio, Inc.
Reported diluted EPS by fiscal period (SEC EDGAR). Chart & overview →
1–15 of 15
| Q1 2026 | 2026-03-31 | -1.69 | 2026-05-07 | 10-Q |
| FY 2025 | 2025-12-31 | -12.48 | 2026-03-12 | 10-K |
| Q3 2025 | 2025-09-30 | -7.16 | 2025-11-12 | 10-Q |
| Q2 2025 | 2025-06-30 | -5.24 | 2025-08-12 | 10-Q |
| Q1 2026 | 2025-03-31 | -2.49 | 2026-05-07 | 10-Q |
| FY 2025 | 2024-12-31 | -9.37 | 2026-03-12 | 10-K |
| Q3 2025 | 2024-09-30 | -7.11 | 2025-11-12 | 10-Q |
| Q2 2025 | 2024-06-30 | -4.87 | 2025-08-12 | 10-Q |
| Q1 2025 | 2024-03-31 | -2.44 | 2025-05-07 | 10-Q |
| FY 2024 | 2023-12-31 | -53.08 | 2025-03-18 | 10-K |
| Q3 2024 | 2023-09-30 | -200.94 | 2024-11-12 | 10-Q |
| Q2 2024 | 2023-06-30 | -135.96 | 2024-08-13 | 10-Q |
| Q1 2024 | 2023-03-31 | -72.20 | 2024-05-14 | 10-Q |
| FY 2023 | 2022-12-31 | -227.42 | 2024-03-26 | 10-K |
| Q3 2023 | 2022-09-30 | -1.83 | 2023-11-02 | 10-Q |
Source: SEC EDGAR / XBRL (reported actuals; no consensus estimates). Informational only — not financial advice.